Articles tagged with Blood Cells
K-State researchers aim to develop a chemical that can close gap junctions, preventing the spread of damaged eye cells. The team faces challenges in delivering the chemical into the eye without causing damage to the retina.
Researchers are exploring a new approach to treating blood cancers by exploiting the natural process of programmed cell death, known as apoptosis. This could potentially kill tumour cells more effectively and improve treatment outcomes. The Leukemia and Lymphoma Society is providing strong support for this research.
Researchers at Johns Hopkins Medicine have successfully grown human stem cells in a lab setting that mirrors the natural developmental process of blood cells. The study provides unprecedented insight into how stem cells specialize into blood cells, shedding light on the mechanisms behind leukemia and lymphoma.
The Duke team successfully engineered new blood vessels from vascular cells of four elderly men with heart disease, extending their lifespan indefinitely. The treated smooth muscle cells were then impregnated into a biodegradable polymer tube and grew for up to seven weeks, forming functional-like arteries.
EndGenitor Technologies Inc. will market test kits for researchers to detect endothelial stem and progenitor cells, which can be used to treat chronic degenerative diseases associated with aging. The company aims to create cell therapy products using the 'ancestor' cells discovered by Drs. Mervin C. Yoder Jr. and David A. Ingram Jr.
Enterococcus faecalis uses a Sonar-like system to detect human blood cells and produce a toxin in response, providing a potential mechanism for developing new antibiotic treatments. This discovery could also be adapted to help the aging population cope with vision loss.
Researchers discovered tPA's toxic effects on brain cells and blood vessels, leading to devastating brain injuries. A compound called APC counters these harmful effects, showing promise for improved stroke therapy.
Researchers discover that Kaposi's sarcoma virus can reprogram blood vessel endothelial cells into lymphatic cells, driven by the gene Prox1. This finding provides a potential target for new therapies against the disease.
Researchers have identified a potential new source of stem cells for treating liver damage, offering hope for improved care. The study found that umbilical cord blood cells may differentiate into functional liver cells after transplantation, providing a promising therapeutic avenue for acute and chronic liver injury therapy.
Researchers found that adult cells descended from renin-producing cells can re-express the renin gene in response to stress, revealing a 'memory' of their original lineage. This ability allows these cells to rapidly respond to changes in blood pressure and sodium levels.
A study by Lund scientists has shown that adult stem cells cannot form new heart muscle cells after a heart attack. The transplanted cells retain their identity as blood cells and fuse with heart muscle cells outside the infarcted area.
A new MRI technique allows researchers to capture moving images of blood traveling through vessels non-invasively. This technology can easily be applied to existing MRI machines, enabling real-time physician-scanner interaction and detailed analysis of cardiovascular disease.
Research suggests that bone-marrow-derived stem cells do not differentiate into new heart muscle cells when injected into damaged hearts. Instead, they mature into traditional blood lineage cells. This challenges the idea of using stem cell therapy to repair damaged hearts and raises questions about alternative approaches.
The Mixed-Lineage Leukemia (MLL) gene plays a crucial role in blood cell development, with its absence resulting in the failure to produce normal blood cells. MLL regulates critical genes necessary for hematopoiesis, a complex process of blood cell formation.
Researchers have discovered a link between the ratio of two energy-compounds and increased blood flow in brain cells. By modulating this ratio, scientists can better understand how blood circulation is activated in the brain, potentially leading to new treatments for diseases like Alzheimer's and diabetes.
Researchers at the University of Rochester Medical Center have identified a key role for bone-forming osteoblasts in controlling the expansion of blood-forming stem cells. The discovery could lead to new treatments for bone marrow-transplant patients, who often face challenges due to limited stem cell availability.
A UCSF-led study found no evidence of trans-differentiation when bone marrow-derived cells fused with damaged tissue in mice, casting doubt on their potential as a treatment for brain and heart diseases. The researchers suggest that cell fusion might be a physiological mechanism for repairing damaged cells, but more research is needed.
Researchers found that zebrafish mutants with severe anemia had a mutation in the cdx4 gene, which led to improved blood cell development when hox genes were injected. This study provides insights into normal blood formation and may lead to more effective treatments for devastating blood disorders like leukemia.
Researchers found that eliminating or overexpressing the cdx4 gene affected blood-cell formation and Hox gene expression in zebrafish. The study's findings could help reveal how cdx4 fusions disrupt normal hematopoiesis and contribute to human leukemias.
Researchers have discovered a genetic signature, known as the IFN expression signature, associated with severe lupus symptoms. This signature is linked to interferon activity and has implications for developing new therapies to block IFN pathways in patients with severe lupus.
Researchers developed a system to study blood vessel development without mural cells, revealing that angiopoietin-1 partially restores large vessel structure. The study suggests Ang1 is crucial for normal vessel stability and highlights the importance of pericytes in maintaining vascular networks.
A recent study has found that gut bacteria interact with the intestine to regulate blood supply, with Bacteroides thetaiotaomicron stimulating blood vessel development. The research suggests a key developmental program shared by intestinal bacteria and their host is essential for healthy development.
Researchers found that cord blood cells improved neurological function in rats with traumatic brain injury, suggesting a new approach for treating this condition. The cells helped promote brain self-repair by stimulating trophic factors and cytokines, which led to better movement, balance, and reflex responses.
Researchers discovered the ancestral role of VEGF protein guiding developing blood cells to their destinations. The findings suggest that blood vessels may have evolved from blood cells, a theory supported by studies on fruit fly embryos.
Dartmouth Medical School biochemists identify a transport receptor that selects soluble proteins for export from cells, resolving a long-standing puzzle. The discovery opens up new avenues for understanding protein secretion and its role in diseases such as hemophilia.
Researchers found that human umbilical cord blood cells improved motor and sensory abilities in rats after stroke, even when administered a week after onset. The study suggests these cells may be used to treat early stroke and other traumatic brain injuries through less invasive IV administration.
Researchers found that bone marrow-derived cells contribute to tumor blood vessel formation and promote growth. Targeting specific VEGF receptors blocks tumor formation, offering potential new therapeutic approaches.
Researchers discovered that blood vessels signal pancreatic cell differentiation, challenging the long-held assumption that organs develop independently. The study found that removing blood vessels from pancreatic tissue disrupts normal gene expression and insulin production.